参苓白术散加减治疗慢性肠炎55例疗效观察
|
摘要
为观察参苓白术散治疗慢性肠炎患者的临床效果,并分析其应用价值和安全性。选取2016年7月至2018年8月确诊为慢性肠炎患者110例,按患者入院进行诊治的先后时间顺序随机分为观察组和对照组,每组55例。观察组采用口服参苓白术散加减治疗,对照组采用口服诺氟沙星治疗,比较2组患者疗效、治疗前后症状(腹痛、大便次数、肛门坠胀、镜检)积分以及治疗半年后2组患者的复发和不良反应情况。结果显示,观察组患者在疗效、各项症状积分及复发率方面均显著优于对照组(P <0.05)。结果表明,慢性肠炎患者采用参苓白术散加减治疗疗效显著,可明显改善临床症状,有效降低复发率,且安全性高。
This study was to observe the clinical effect of chronic enteronitis(CE)treated with modified Shenling Baizhu San(a TCM formula,powder,shortly named:San),to analyse its application value and safety,enrolled 110 patients with confirmed CE(2016-07-2018-08),and randomly divided them into observation group(55 cases,oral administered San modified)and control one(55 cases,oral administered Norfloxacin)and compared effect,the score on symptoms(abdominal pain,the frequency of defecation,tenesmus of anus,and enteroscopy finding),and the status on recurrence and adverse reaction at 0.5 years after treatment between the two groups.As results,in above all indexes observation group was all superior to control one(P <0.05).Results show that for CE the San modified has significant effect,can greatly improve patients' clinical symptoms,effectively decline recurrence rate,and with high safety.
This study was to observe the clinical effect of chronic enteronitis(CE)treated with modified Shenling Baizhu San(a TCM formula,powder,shortly named:San),to analyse its application value and safety,enrolled 110 patients with confirmed CE(2016-07-2018-08),and randomly divided them into observation group(55 cases,oral administered San modified)and control one(55 cases,oral administered Norfloxacin)and compared effect,the score on symptoms(abdominal pain,the frequency of defecation,tenesmus of anus,and enteroscopy finding),and the status on recurrence and adverse reaction at 0.5 years after treatment between the two groups.As results,in above all indexes observation group was all superior to control one(P <0.05).Results show that for CE the San modified has significant effect,can greatly improve patients' clinical symptoms,effectively decline recurrence rate,and with high safety.
引文
[1]吴文岭,王怀璋.参苓白术散加减治疗溃疡性结肠炎疗效观察[J].中医学报,2013,28(9):1392-1393.
[2]陈敏,黄德铨,肖飏,等.曹吉勋教授治疗慢性肠炎的中医处方用药规律分析[J].成都中医药大学学报,2016,39(3):85-89.
[3]崔国宁,刘喜平,董俊刚.溃疡性结肠炎研究进展[J].山西中医学院学报,2017,18(5):71-73.
[4]杨丽华,李学彪,陈生民.46例急性胃肠炎的临床治疗分析[J].中国医药指南,2013,11(18):491-492.
[5]李玉香,董凤华.20例慢性结肠炎临床诊治分析[J].中国实用医药,2015,10(9):171-172.
[6]施亚芹.中药治疗慢性肠炎5法[J].中国社区医师,2016,32(23):120.
[7]马青松.中医药健肠饮治疗慢性肠炎的疗效分析[J].中国保健营养(下旬刊),2013,23(7):4073-4074.
[8]霍冬梅.中西医结合治疗慢性结肠炎60例临床研究[J].中国医药指南,2016,14(33):173.
[2]陈敏,黄德铨,肖飏,等.曹吉勋教授治疗慢性肠炎的中医处方用药规律分析[J].成都中医药大学学报,2016,39(3):85-89.
[3]崔国宁,刘喜平,董俊刚.溃疡性结肠炎研究进展[J].山西中医学院学报,2017,18(5):71-73.
[4]杨丽华,李学彪,陈生民.46例急性胃肠炎的临床治疗分析[J].中国医药指南,2013,11(18):491-492.
[5]李玉香,董凤华.20例慢性结肠炎临床诊治分析[J].中国实用医药,2015,10(9):171-172.
[6]施亚芹.中药治疗慢性肠炎5法[J].中国社区医师,2016,32(23):120.
[7]马青松.中医药健肠饮治疗慢性肠炎的疗效分析[J].中国保健营养(下旬刊),2013,23(7):4073-4074.
[8]霍冬梅.中西医结合治疗慢性结肠炎60例临床研究[J].中国医药指南,2016,14(33):173.